Institutional investors purchased a net $317.6 thousand shares of SPNC during the quarter ended September 2015 and now own 111.67% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BALYASNY ASSET MANAGEMENT LP Bought 1.4 Million shares of Spectranetics Corp
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 1.1 Million shares of Spectranetics Corp